While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...

Jim Gaffigan has revealed using a weight-loss drug gave him a "better life". The comedian wants to challenge the stigma ...

Millions in South Africa face rising diabetes treatment costs and limited access to insulin pens, sparking protests.

The popularity of weight loss drugs such as Ozempic and Mounjaro continue to reflect Americans’ desire to slim down. While ...

Gaffigan slimmed down using Mounjaro, which is a brand name for tirzepatide, a prescription drug used to treat type 2 ...

Jim Gaffigan isn't ashamed to admit he jumped on the weight-loss medication bandwagon. In a new interview, the comedian ...

Jim Gaffigan has a sleek new look to match his recent Hollywood renaissance, which includes his hilarious turn on SNL as vice ...

Eli Lilly's Phase 3 study shows tirzepatide significantly cuts type 2 diabetes risk and supports 22.9% average weight loss in adults over three years.

A phase 3 trial found that Eli Lilly's tirzepatide significantly reduced the risk of progression to Type 2 diabetes in prediabetic adults over a three-year period. Nearly 99% of individuals treated ...

Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...

KNOXVILLE, Tenn. – Kalen DeBoer's message to Alabama football Saturday night after the Crimson Tide's 24-17 loss to Tennessee was simple. Look inward. Do some soul-searching. Get back to work.

Has something changed regarding Eli Lilly or Regeneron's thesis, or is the recent dip an excellent opportunity to invest in ...